Europe providing funding for cancer biomarkers; Melanoma biomarker assay to enter validation studies;

> OracleBio has signed an agreement with RedX Pharma for translational biomarker services for preclinical R&D. Release

> Canada's PROOF Centre has licensed the GVK Bio Online Clinical Biomarker Database to help develop biomarkers for heart, lung and kidney failure. Item

> BBVA Foundation is funding a Massachusetts General and Vall d'Hebrón Institute of Oncology collaboration over cancer biomarkers. Announcement

> DermTech's melanoma biomarker assay is set to enter validation studies. Press release

> Europe is providing funding for cancer biomarkers, helping to push forward personalized medicine. More

> MDxHealth says a prototype of its Prostate ConfirmMDx test can help urologists tell the difference between patients who have a true negative biopsy from those who may have cancer. The company plans to launch an epigenetics test in 2012. Press release

> Sera Prognostics has secured $19.3 million in a Series A round of funding to support the launch of biomarker-based preterm birth predictor. Press release

> Could apolipoprotein E be a biomarker for MCI? Abstract

And Finally... Researchers have created a mathematical model for ovarian cancer based on the biomarker CA125, which shows that tumors could exist for up to 10 years before being detectable by current blood tests. Item

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.